COVID-19: What are best practices for informed consent in CTIMPs? How can we help ensure these though Quality Management and Audit?
Webinar - Free Q&A Session
|Date(s)||07 Jun. 2021|
|Day(s)||17:00 - 18:00|
Our Free of Charge weekly Q&A Webinars on Clinical Trials During the Corona Virus Pandemic are continuing!
Quality and ethics experts respond to your questions from sponsor and site points of view.
Opening of the Webinar
Moderator(s): Hugh Davies, National Research Ethics Service
The ethical requirements for consent processes: what RECs look for
Heather Sampson, University of Toronto
Hugh Davies, National Research Ethics Service
Quality management and consent: what QA is looking for
Seif Eddine Amara Madi, GSK
Open discussion and comment: “Good consent practice”Open discussion and comment: “Good consent practice”
Audit/Inspection and consent : standards, what we do now, what might be critical findings when auditing consent?
Belinda Pearce, BP Quality Solution
Panel and audience discussion : “Matching these up – how can QM and audit help?
Beat Widler, WS QMS
Cathy Dove, Dove Quality Solutions
Louise Mawer, Mirabilitas
Mark Poulton, Poulton Quality Solutions
End of the Webinar